These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18304215)

  • 21. Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis.
    Khan AJ; Ruwali M; Choudhuri G; Mathur N; Husain Q; Parmar D
    Mutat Res; 2009 May; 664(1-2):55-63. PubMed ID: 19428381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathione S-transferase M1 genotypes and the risk of anal cancer: a population-based case-control study.
    Chen C; Madeleine MM; Lubinski C; Weiss NS; Tickman EW; Daling JR
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):985-91. PubMed ID: 8959321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
    Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
    Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
    González A; Ramírez V; Cuenca P; Sierra R
    Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
    Rothman N; Hayes RB; Zenser TV; DeMarini DM; Bi W; Hirvonen A; Talaska G; Bhatnagar VK; Caporaso NE; Brooks LR; Lakshmi VM; Feng P; Kashyap SK; You X; Eischen BT; Kashyap R; Shelton ML; Hsu FF; Jaeger M; Parikh DJ; Davis BB; Yin S; Bell DA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):979-83. PubMed ID: 8959320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer.
    Giannakopoulos X; Charalabopoulos K; Baltogiannis D; Chatzikiriakidou A; Alamanos Y; Georgiou I; Evangelou A; Agnantis N; Sofikitis N
    Anticancer Res; 2002; 22(6B):3801-4. PubMed ID: 12552997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors.
    De Roos AJ; Rothman N; Inskip PD; Linet MS; Shapiro WR; Selker RG; Fine HA; Black PM; Pittman GS; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):14-22. PubMed ID: 12540498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina.
    Moore LE; Wiencke JK; Bates MN; Zheng S; Rey OA; Smith AH
    Cancer Lett; 2004 Aug; 211(2):199-207. PubMed ID: 15219943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population.
    Soya SS; Vinod T; Reddy KS; Gopalakrishnan S; Adithan C
    Eur J Cancer; 2007 Dec; 43(18):2698-706. PubMed ID: 17707637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study.
    Brockmöller J; Kerb R; Drakoulis N; Staffeldt B; Roots I
    Cancer Res; 1994 Aug; 54(15):4103-11. PubMed ID: 8033143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
    Liu R; Yin LH; Pu YP
    Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
    Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
    Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians.
    Nishimoto IN; Hanaoka T; Sugimura H; Nagura K; Ihara M; Li XJ; Arai T; Hamada GS; Kowalski LP; Tsugane S
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):675-80. PubMed ID: 10919737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study.
    Zupa A; Sgambato A; Bianchino G; Improta G; Grieco V; LA Torre G; Campisi B; Traficante A; Aieta M; Cittadini A
    Anticancer Res; 2009 May; 29(5):1709-14. PubMed ID: 19443391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of polymorphisms of glutathione S-transferases M1 and M3 on the development of human urothelial cancer.
    Golka K; Schmidt T; Seidel T; Dietrich H; Roemer HC; Lohlein D; Reckwitz T; Sokeland J; Weistenhofer W; Blaszkewicz M; Selinski S
    J Toxicol Environ Health A; 2008; 71(13-14):881-6. PubMed ID: 18569590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women.
    Yang XR; Wacholder S; Xu Z; Dean M; Clark V; Gold B; Brown LM; Stone BJ; Fraumeni JF; Caporaso NE
    Cancer Lett; 2004 Oct; 214(2):197-204. PubMed ID: 15363546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic polymorphisms of cytochrome P450 2E1 and glutathione S-transferase P1 and susceptibility to esophageal cancer].
    Lin D; Tang Y; Peng Q
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):94-7. PubMed ID: 10920953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
    Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.